Skip to content

Drug interactions

Carmustine + Trastuzumab

Severity: Moderate

Carmustine and Trastuzumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carmustine causes delayed, prolonged bone marrow suppression, and trastuzumab combined with cytotoxic therapy has been linked to more neutropenia and febrile neutropenia. The combination may raise the risk of infection.

What this interaction means in plain words

Carmustine and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Carmustine belongs to Oncology; Trastuzumab belongs to Oncology.

Evidence level: Low

Why it happens

Additive myelosuppression, driven mainly by the alkylating effect of carmustine on bone marrow.

What to do

Monitor complete blood counts, including nadir counts over several weeks, and watch for infection. Adjust carmustine dosing or give growth factor support if marked cytopenias occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carmustine and Trastuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Carmustine with Trastuzumab?

MediHelp rates the interaction as moderate. Carmustine and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Carmustine causes delayed, prolonged bone marrow suppression, and trastuzumab combined with cytotoxic therapy has been linked to more neutropenia and febrile neutropenia. The combination may raise the risk of infection.

How serious is the interaction between Carmustine and Trastuzumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts, including nadir counts over several weeks, and watch for infection. Adjust carmustine dosing or give growth factor support if marked cytopenias occur.

What other medicines interact with Trastuzumab?

MediHelp also lists interactions of Trastuzumab with, for example, Daunorubicin, Doxorubicin liposomal, Doxorubicin. The full list is on the Trastuzumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in